United States Urological Device Market Snapshot
Fueled by persistent obesity rates, rising kidney stone prevalence, and an expanding aging population, the US urological device market will grow steadily through 2034. Growth will be supported by increasing demand for BPH devices—particularly Aquablation—single-use endoscopes, and UI devices. The ongoing shift toward value-based care also favors the adoption of minimally invasive urological treatments that reduce hospital stay and recovery time. However, the demand for select product categories, such as Foley catheters, will be curbed by infection concerns, while urethral bulking agent procedures continue to face competition from physician-favored sling techniques. Moreover, prolonged safety concerns and past litigation will restrain genitourinary mesh device sales in the US market.
Read our Market Snapshot to access comprehensive data and analysis on the state of the market for urological devices in the US from 2019 through 2034.
Related insights
The latest news, technologies, and resources from our team.
